Fidelity Disruptive Medicine ETF (FMED) Institutional Ownership

$24.88
+0.20 (+0.81%)
(As of 05/7/2024 ET)

Institutional Ownership Changes (13F Filings) for Fidelity Disruptive Medicine ETF (NASDAQ:FMED)

Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$748.73K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$435.91K
Get FMED Insider Trade Alerts

Want to know when executives and insiders are buying or selling Fidelity Disruptive Medicine ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Fidelity Disruptive Medicine ETF Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/16/2024 Wealth Enhancement Advisory Services LLC496,857$12.68M0.0%+6.3%23.437%
11/13/2023FMR LLC737,997$16.33M0.0%-2.6%34.811%
(Data available from 1/1/2016 forward)

FMED Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of FMED shares?

During the previous two years, the following institutional investors and hedge funds held shares of Fidelity Disruptive Medicine ETF shares: FMR LLC ($16.33M), Wealth Enhancement Advisory Services LLC ($12.68M).Learn more on FMED's institutional investors.

Which institutional investors have been buying Fidelity Disruptive Medicine ETF stock?

The following institutional investors have purchased Fidelity Disruptive Medicine ETF stock in the last 24 months: Wealth Enhancement Advisory Services LLC ($29.34K).

How much institutional buying is happening at Fidelity Disruptive Medicine ETF?

Institutional investors have bought a total of 29,339 shares in the last 24 months. This purchase volume represents approximately $748.73K in transactions.

Which Fidelity Disruptive Medicine ETF major shareholders have been selling company stock?

The following institutional investors have sold Fidelity Disruptive Medicine ETF stock in the last 24 months: FMR LLC ($19.70K).

How much institutional selling is happening at Fidelity Disruptive Medicine ETF?

Institutional investors have sold a total of 19,697 shares in the last 24 months. This volume of shares sold represents approximately $435.91K in transactions.


This page (NASDAQ:FMED) was last updated on 5/7/2024 by MarketBeat.com Staff

From Our Partners